MX383494B - Ácidos nucleicos libres de células para el análisis del microbioma humano y componentes del mismo. - Google Patents
Ácidos nucleicos libres de células para el análisis del microbioma humano y componentes del mismo.Info
- Publication number
- MX383494B MX383494B MX2016005798A MX2016005798A MX383494B MX 383494 B MX383494 B MX 383494B MX 2016005798 A MX2016005798 A MX 2016005798A MX 2016005798 A MX2016005798 A MX 2016005798A MX 383494 B MX383494 B MX 383494B
- Authority
- MX
- Mexico
- Prior art keywords
- analysis
- components
- cell
- nucleic acids
- free nucleic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/20—Sequence assembly
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Virology (AREA)
- Pathology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361901114P | 2013-11-07 | 2013-11-07 | |
| US201361901857P | 2013-11-08 | 2013-11-08 | |
| PCT/US2014/064669 WO2015070086A1 (en) | 2013-11-07 | 2014-11-07 | Cell-free nucleic acids for the analysis of the human microbiome and components thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016005798A MX2016005798A (es) | 2016-11-28 |
| MX383494B true MX383494B (es) | 2025-03-14 |
Family
ID=53042160
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016005798A MX383494B (es) | 2013-11-07 | 2014-11-07 | Ácidos nucleicos libres de células para el análisis del microbioma humano y componentes del mismo. |
| MX2021006893A MX2021006893A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
| MX2021006897A MX2021006897A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
| MX2020004247A MX2020004247A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
| MX2021006895A MX2021006895A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021006893A MX2021006893A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
| MX2021006897A MX2021006897A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
| MX2020004247A MX2020004247A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
| MX2021006895A MX2021006895A (es) | 2013-11-07 | 2016-05-04 | Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo. |
Country Status (12)
| Country | Link |
|---|---|
| US (6) | US10450620B2 (https=) |
| EP (2) | EP3066236B1 (https=) |
| JP (4) | JP7451070B2 (https=) |
| KR (4) | KR102930443B1 (https=) |
| CN (2) | CN112877472A (https=) |
| AU (1) | AU2014346562B2 (https=) |
| BR (1) | BR112016010095A2 (https=) |
| CA (2) | CA2929557C (https=) |
| GB (1) | GB2535382A (https=) |
| IL (4) | IL285106B (https=) |
| MX (5) | MX383494B (https=) |
| WO (1) | WO2015070086A1 (https=) |
Families Citing this family (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| AU2011358564B9 (en) | 2011-02-09 | 2017-07-13 | Natera, Inc | Methods for non-invasive prenatal ploidy calling |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| JP7451070B2 (ja) | 2013-11-07 | 2024-03-18 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ヒトミクロビオームおよびその成分の分析のための無細胞核酸 |
| CN104946737B (zh) | 2013-12-11 | 2019-02-22 | 安可济控股有限公司 | 用于检测罕见序列变体的组合物和方法 |
| US11859246B2 (en) * | 2013-12-11 | 2024-01-02 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
| EP3957749A1 (en) | 2014-04-21 | 2022-02-23 | Natera, Inc. | Detecting tumour specific mutations in biopsies with whole exome sequencing and in cell-free samples |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| US10410749B2 (en) | 2014-10-21 | 2019-09-10 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions |
| US10325685B2 (en) | 2014-10-21 | 2019-06-18 | uBiome, Inc. | Method and system for characterizing diet-related conditions |
| AU2015335907A1 (en) | 2014-10-21 | 2017-04-13 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
| CA2971444A1 (en) | 2014-12-20 | 2016-06-23 | Arc Bio, Llc | Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using crispr/cas system proteins |
| WO2016109939A1 (zh) * | 2015-01-06 | 2016-07-14 | 深圳市海普洛斯生物科技有限公司 | 一种富集循环肿瘤dna的方法和试剂 |
| US10893509B2 (en) | 2015-02-11 | 2021-01-12 | Qualcomm Incorporated | Multiple tri-state HARQ processes |
| WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
| CN107922971A (zh) * | 2015-05-18 | 2018-04-17 | 凯锐思公司 | 用于富集核酸群体的组合物和方法 |
| WO2017004379A1 (en) * | 2015-06-30 | 2017-01-05 | uBiome, Inc. | Method and system for diagnostic testing |
| AU2016308283B2 (en) | 2015-08-19 | 2022-04-21 | Arc Bio, Llc | Capture of nucleic acids using a nucleic acid-guided nuclease-based system |
| EP3347496A4 (en) * | 2015-09-09 | 2019-08-07 | Ubiome Inc. | METHOD AND SYSTEM FOR DIAGNOSES DERIVED FROM MICROBIOMA AND THERAPEUTIC TREATMENTS FOR BUCCO-DENTAL HEALTH |
| EP3347495A4 (en) * | 2015-09-09 | 2019-08-21 | Ubiome, Inc. | METHOD AND SYSTEM FOR MICROBIOMY-DERIVED DIAGNOSES AND THERAPEUTIC AGENTS FOR DISEASES ASSOCIATED WITH GASTROINTESTINAL HEALTH |
| EP3141612A1 (en) | 2015-09-10 | 2017-03-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Method and device for nucleic acid based diagnostic approaches including the determination of a deviant condtion, especially a health condition and/or pathogenic condition of a sample |
| EP3146974A1 (en) * | 2015-09-25 | 2017-03-29 | Universite Claude Bernard - Lyon 1 | Biomarkers for early determination of severity of influenza related disease |
| AU2016334233B2 (en) | 2015-10-09 | 2023-01-05 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
| CN108699505A (zh) | 2015-12-03 | 2018-10-23 | 安可济控股有限公司 | 用于形成连接产物的方法和组合物 |
| CN105567831B (zh) * | 2016-01-29 | 2019-07-23 | 江汉大学 | 一种食品微生物定性与定量的检测方法 |
| CN105603074B (zh) * | 2016-01-29 | 2019-11-15 | 江汉大学 | 一种非诊断目的微生物定性与定量的检测方法 |
| CN105671150A (zh) * | 2016-01-29 | 2016-06-15 | 江汉大学 | 一种人体微生物定性与定量的检测方法 |
| CN105603076A (zh) * | 2016-01-29 | 2016-05-25 | 江汉大学 | 一种土壤微生物定性与定量的检测方法 |
| CN105603075A (zh) * | 2016-01-29 | 2016-05-25 | 江汉大学 | 一种小麦微生物定性与定量的检测方法 |
| CA3185611A1 (en) | 2016-03-25 | 2017-09-28 | Karius, Inc. | Synthetic nucleic acid spike-ins |
| WO2017181202A2 (en) | 2016-04-15 | 2017-10-19 | Natera, Inc. | Methods for lung cancer detection |
| CA3022294A1 (en) * | 2016-04-25 | 2017-11-02 | uBiome, Inc. | Method and system for characterizing skin-related conditions |
| CA3024630A1 (en) | 2016-05-16 | 2017-11-23 | Accuragen Holdings Limited | Method of improved sequencing by strand identification |
| FR3051482B1 (fr) * | 2016-05-19 | 2021-01-29 | Life & Soft | Procede de determination de la presence et quantification d'au moins un micro-organisme dans un echantillon biologique |
| EP4257701A3 (en) * | 2016-06-30 | 2023-12-20 | Grail, LLC | Differential tagging of rna for preparation of a cell-free dna/rna sequencing library |
| CA3033749C (en) | 2016-08-15 | 2026-03-24 | Accuragen Holdings Limited | Compositions and methods for detecting rare sequence variants |
| US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| WO2018094183A1 (en) * | 2016-11-17 | 2018-05-24 | Seracare Life Sciences, Inc. | Methods for preparing dna reference material and controls |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| JP2020515278A (ja) * | 2017-04-04 | 2020-05-28 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ドナー遺伝子型の非存在下での移植由来循環セルフリーｄｎａの定量化 |
| WO2018187521A2 (en) * | 2017-04-06 | 2018-10-11 | Cornell University | Methods of detecting cell-free dna in biological samples |
| WO2018191563A1 (en) | 2017-04-12 | 2018-10-18 | Karius, Inc. | Sample preparation methods, systems and compositions |
| EP3431610A1 (en) * | 2017-07-19 | 2019-01-23 | Noscendo GmbH | Methods and devices for nucleic acid-based real-time determination of disease states |
| US11519024B2 (en) | 2017-08-04 | 2022-12-06 | Billiontoone, Inc. | Homologous genomic regions for characterization associated with biological targets |
| US11430543B2 (en) | 2017-08-04 | 2022-08-30 | Billiontoone, Inc. | Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targets |
| EP3662480A4 (en) | 2017-08-04 | 2021-05-19 | BillionToOne, Inc. | MOLECULES ASSOCIATED WITH A TARGET FOR A CHARACTERIZATION ASSOCIATED WITH BIOLOGICAL TARGETS |
| WO2019060716A1 (en) | 2017-09-25 | 2019-03-28 | Freenome Holdings, Inc. | SAMPLE EXTRACTION METHODS AND SYSTEMS |
| JP2021506342A (ja) | 2017-12-14 | 2021-02-22 | ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． | 移植のための移植片適合性の評価 |
| ES2970286T3 (es) | 2018-01-05 | 2024-05-27 | Billiontoone Inc | Plantillas de control de calidad para garantizar la validez de ensayos basados en secuenciación |
| US12398389B2 (en) | 2018-02-15 | 2025-08-26 | Natera, Inc. | Methods for isolating nucleic acids with size selection |
| JP2021518106A (ja) * | 2018-03-13 | 2021-08-02 | ガーダント ヘルス， インコーポレイテッド | 治療用核酸構築物の非侵襲的な検出およびモニタリングのための方法 |
| WO2019178157A1 (en) | 2018-03-16 | 2019-09-19 | Karius, Inc. | Sample series to differentiate target nucleic acids from contaminant nucleic acids |
| EP3785269A4 (en) * | 2018-03-29 | 2021-12-29 | Freenome Holdings, Inc. | Methods and systems for analyzing microbiota |
| CA3090426A1 (en) | 2018-04-14 | 2019-10-17 | Natera, Inc. | Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna |
| CN108660199A (zh) * | 2018-05-20 | 2018-10-16 | 北京宏微特斯生物科技有限公司 | 一种基于cfDNA高通量测序检测病原体的方法 |
| US12049665B2 (en) | 2018-06-12 | 2024-07-30 | Accuragen Holdings Limited | Methods and compositions for forming ligation products |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| US12071651B2 (en) | 2018-08-06 | 2024-08-27 | Billiontoone, Inc. | Dilution tagging for quantification of biological targets |
| KR102114758B1 (ko) * | 2018-11-19 | 2020-05-26 | 경북대학교 산학협력단 | 멤브레인 구조물을 이용한 혈액 내 미생물의 핵산 추출을 위한 혈액 시료 전처리 방법 |
| ES3059710T3 (en) | 2018-11-21 | 2026-03-23 | Karius Inc | Direct-to-library methods, systems, and compositions |
| US11512349B2 (en) | 2018-12-18 | 2022-11-29 | Grail, Llc | Methods for detecting disease using analysis of RNA |
| WO2020198664A1 (en) * | 2019-03-28 | 2020-10-01 | The Regents Of The University Of California | Methods and systems for sequencing cell-free microbiome dna |
| AU2020283042B2 (en) | 2019-05-31 | 2026-02-19 | Freenome Holdings, Inc. | Methods and systems for high-depth sequencing of methylated nucleic acid |
| KR102503766B1 (ko) * | 2020-06-16 | 2023-02-23 | 씨제이바이오사이언스 주식회사 | 장내 마이크로바이옴 지수를 결정하기 위한 장치, 방법 및 명령을 기록한 기록 매체 |
| US20240071616A1 (en) * | 2020-11-12 | 2024-02-29 | Micronoma, Inc. | Systems and methods to improve therapeutic outcomes |
| US20220195496A1 (en) * | 2020-12-17 | 2022-06-23 | Karius, Inc. | Sequencing microbial cell-free dna from asymptomatic individuals |
| EP4263866A4 (en) * | 2020-12-21 | 2024-12-04 | Karius, Inc. | Sequencing microbial cell-free nucleic acids to detect inflammation, secondary infection, and disease severity |
| CN113061666A (zh) * | 2020-12-30 | 2021-07-02 | 中南大学湘雅二医院 | 肝移植后巨细胞病毒的检测方法、应用及系统 |
| CA3213399A1 (en) * | 2021-03-18 | 2022-09-22 | Natera, Inc. | Methods for determination of transplant rejection |
| AU2022325908A1 (en) * | 2021-08-11 | 2024-01-04 | Immunosis Pty Ltd | Methods for determining secondary immunodeficiency |
| CA3249869A1 (en) * | 2022-01-24 | 2023-07-27 | Gusto Global, Llc | SINGLE-POINT TARGETED AMPLICO FRAGMENT SEQUENCING AT SINGLE AND MULTI-LOCI LOCI |
| JP2025509878A (ja) | 2022-03-21 | 2025-04-11 | ビリオントゥーワン，インコーポレイテッド | 処置モニタリングのためのメチル化セルフリーｄｎａの分子計数 |
| WO2025024111A1 (en) * | 2023-07-25 | 2025-01-30 | Gusto Global, Llc | Single point amplicon fragment sequencing and methods for diagnosing and monitoring disease |
| TW202536192A (zh) * | 2023-10-24 | 2025-09-16 | 創新診斷科技中心 | 用於疾病分類之微生物ｄｎａ分析 |
| US20250191691A1 (en) * | 2023-12-07 | 2025-06-12 | California Institute Of Technology | Methods for the translated alignment of transcriptomic data at single-cell resolution |
| WO2025175229A1 (en) * | 2024-02-16 | 2025-08-21 | Karius, Inc. | Multi-step methods for detecting nucleic acids |
| WO2025231437A1 (en) * | 2024-05-03 | 2025-11-06 | Karius, Inc. | Predicting cytokine release syndrome in car-t cell therapy |
Family Cites Families (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US4988617A (en) | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
| US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
| US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
| US6969488B2 (en) | 1998-05-22 | 2005-11-29 | Solexa, Inc. | System and apparatus for sequential processing of analytes |
| USRE39920E1 (en) | 1997-05-30 | 2007-11-13 | Xenomics, Inc. | Methods for detection of nucleic acid sequences in urine |
| US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
| US20030022207A1 (en) | 1998-10-16 | 2003-01-30 | Solexa, Ltd. | Arrayed polynucleotides and their use in genome analysis |
| US7056661B2 (en) | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
| US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| US7244559B2 (en) | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| WO2001023610A2 (en) | 1999-09-29 | 2001-04-05 | Solexa Ltd. | Polynucleotide sequencing |
| US6582938B1 (en) | 2001-05-11 | 2003-06-24 | Affymetrix, Inc. | Amplification of nucleic acids |
| GB0002389D0 (en) | 2000-02-02 | 2000-03-22 | Solexa Ltd | Molecular arrays |
| AU2001293163A1 (en) | 2000-09-27 | 2002-04-08 | Lynx Therapeutics, Inc. | Method for determining relative abundance of nucleic acid sequences |
| US6753137B2 (en) | 2001-01-31 | 2004-06-22 | The Chinese University Of Hong Kong | Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma |
| US6996477B2 (en) | 2001-04-19 | 2006-02-07 | Dana Farber Cancer Institute, Inc. | Computational subtraction method |
| DE10120797B4 (de) | 2001-04-27 | 2005-12-22 | Genovoxx Gmbh | Verfahren zur Analyse von Nukleinsäureketten |
| AU2002337030A1 (en) | 2001-08-29 | 2003-03-18 | Genovoxx Gmbh | Method for analyzing nucleic acid sequences and gene expression |
| JP2003101204A (ja) | 2001-09-25 | 2003-04-04 | Nec Kansai Ltd | 配線基板及び配線基板の製造方法並びに電子部品 |
| DE10246005A1 (de) | 2001-10-04 | 2003-04-30 | Genovoxx Gmbh | Gerät zur Sequenzierung von Nukleinsäuremolekülen |
| DE10149786B4 (de) | 2001-10-09 | 2013-04-25 | Dmitry Cherkasov | Oberfläche für Untersuchungen aus Populationen von Einzelmolekülen |
| US20050124022A1 (en) | 2001-10-30 | 2005-06-09 | Maithreyan Srinivasan | Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| US6902921B2 (en) | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| US20050202414A1 (en) | 2001-11-15 | 2005-09-15 | The Regents Of The University Of California | Apparatus and methods for detecting a microbe in a sample |
| WO2003074740A1 (en) | 2002-03-01 | 2003-09-12 | Ravgen, Inc. | Rapid analysis of variations in a genome |
| US6977162B2 (en) | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
| DE10214395A1 (de) | 2002-03-30 | 2003-10-23 | Dmitri Tcherkassov | Verfahren zur Analyse von Einzelnukleotidpolymorphismen |
| US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
| US7442506B2 (en) | 2002-05-08 | 2008-10-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
| CN1688719A (zh) * | 2002-07-01 | 2005-10-26 | 瓦罗洛吉克公司 | 确定致病性病毒对蛋白酶抑制剂易感性的组合物和方法 |
| WO2005003375A2 (en) | 2003-01-29 | 2005-01-13 | 454 Corporation | Methods of amplifying and sequencing nucleic acids |
| US20040209299A1 (en) | 2003-03-07 | 2004-10-21 | Rubicon Genomics, Inc. | In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA |
| CA2522007A1 (en) | 2003-04-11 | 2004-10-28 | Medimmune, Inc. | Methods of preventing or treating respiratory conditions |
| EP1725572B1 (de) | 2003-11-05 | 2017-05-31 | AGCT GmbH | Makromolekulare nukleotidverbindungen und methoden zu deren anwendung |
| DE10356837A1 (de) | 2003-12-05 | 2005-06-30 | Dmitry Cherkasov | Modifizierte Nukleotide und Nukleoside |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| JP2007515414A (ja) | 2003-12-16 | 2007-06-14 | パレンテラル アー エス | 血漿置換剤およびその製造方法 |
| DE102004009704A1 (de) | 2004-02-27 | 2005-09-15 | Dmitry Cherkasov | Makromolekulare Nukleotidverbindungen und Methoden zu deren Anwendung |
| DE102004025744A1 (de) | 2004-05-26 | 2005-12-29 | Dmitry Cherkasov | Oberfläche für die Analysen an einzelnen Nukleinsäuremolekülen |
| DE102004025746A1 (de) | 2004-05-26 | 2005-12-15 | Dmitry Cherkasov | Verfahren, Oberfläche und Substrate zur hochparallelen Sequenzierung von Nukleinsäureketten |
| DE102004025695A1 (de) | 2004-05-26 | 2006-02-23 | Dmitry Cherkasov | Verfahren und Oberfläche zur parallelen Sequenzierung von Nukleinsäureketten |
| DE102004025745A1 (de) | 2004-05-26 | 2005-12-15 | Cherkasov, Dmitry | Oberfläche für die Analysen an einzelnen Molekülen |
| DE102004025694A1 (de) | 2004-05-26 | 2006-02-23 | Dmitry Cherkasov | Verfahren und Oberfläche zu hochparallelen Analysen von Nukleinsäureketten |
| DE102004025696A1 (de) | 2004-05-26 | 2006-02-23 | Dmitry Cherkasov | Verfahren, Oberfläche und Substrate zu hochparallelen Analysen von Nukleinsäureketten |
| US20060002471A1 (en) | 2004-06-30 | 2006-01-05 | Lippincott Louis A | Motion estimation unit |
| US7276720B2 (en) | 2004-07-19 | 2007-10-02 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
| US20060012793A1 (en) | 2004-07-19 | 2006-01-19 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
| US20060024678A1 (en) | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
| WO2006089203A2 (en) | 2005-02-17 | 2006-08-24 | Istituto Nazionale Per Le Malattie Infettive Irccs Lazzaro Spallanzani | Compositions and methods for detecting viral specific nucleic acids in urine |
| US7914982B2 (en) | 2005-02-17 | 2011-03-29 | Trovagene, Inc. | Methods for detecting pathogen specific nucleic acids in urine |
| ITRM20050068A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine. |
| ITRM20050067A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine. |
| AU2006214444B8 (en) | 2005-02-17 | 2012-04-05 | Trovagene, Inc. | Compositions and methods for detecting pathogen specific nucleic acids in urine |
| US8532930B2 (en) | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
| IES20090464A2 (en) * | 2008-06-13 | 2010-03-03 | Nat Univ Ireland | SWI5 gene as a diagnostic target for the identification of fungal and yeast species |
| ES2595489T3 (es) | 2008-07-18 | 2016-12-30 | Trovagene, Inc. | Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR |
| US20120190663A1 (en) | 2009-08-06 | 2012-07-26 | Cedars-Sinai Medical Center | Use of free dna as an early predictor of severity in acute pancreatitis |
| HUE052213T2 (hu) | 2009-11-06 | 2021-04-28 | Univ Leland Stanford Junior | Grafitkilökõdés nem invazív diagnosztizálása szervátültetett betegekben |
| EP2325312A1 (de) | 2009-11-19 | 2011-05-25 | Qiagen GmbH | Verfahren zur selektiven Anreicherung und Isolierung mikrobieller und optional zusätzlich viraler Nukleinsäuren |
| CN102071261A (zh) * | 2009-11-24 | 2011-05-25 | 上海复星医学科技发展有限公司 | 一种单纯疱疹病毒核酸检测方法及试剂盒 |
| WO2011111966A2 (en) | 2010-03-08 | 2011-09-15 | Celltrion, Inc. | Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| US20120077185A1 (en) | 2010-08-06 | 2012-03-29 | Tandem Diagnostics, Inc. | Detection of genetic abnormalities and infectious disease |
| AU2012236109A1 (en) | 2011-04-01 | 2013-11-21 | Occam Biolabs, Inc. | Methods and kits for detecting cell-free pathogen-specific nucleic acids |
| US20140179726A1 (en) * | 2011-05-19 | 2014-06-26 | Virginia Commonwealth University | Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction |
| EP2718862B1 (en) | 2011-06-06 | 2018-10-31 | Koninklijke Philips N.V. | Method for assembly of nucleic acid sequence data |
| US20130024127A1 (en) | 2011-07-19 | 2013-01-24 | John Stuelpnagel | Determination of source contributions using binomial probability calculations |
| CA2850785C (en) | 2011-10-06 | 2022-12-13 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2013113012A2 (en) | 2012-01-27 | 2013-08-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiling and quantitating cell-free rna |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| JP6411995B2 (ja) | 2012-03-13 | 2018-10-24 | ザ チャイニーズ ユニバーシティー オブ ホンコン | 非侵襲的出生前診断のために大量並列シークエンシング・データを分析する方法 |
| AU2013249012B2 (en) * | 2012-04-19 | 2019-03-28 | The Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free DNA |
| EP2653562A1 (en) | 2012-04-20 | 2013-10-23 | Institut Pasteur | Anellovirus genome quantification as a biomarker of immune suppression |
| WO2013188846A1 (en) | 2012-06-15 | 2013-12-19 | Harry Stylli | Methods of detecting diseases or conditions |
| GB2533006B (en) | 2012-09-04 | 2017-06-07 | Guardant Health Inc | Systems and methods to detect copy number variation |
| US20140066317A1 (en) | 2012-09-04 | 2014-03-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| EP2728014B1 (en) | 2012-10-31 | 2015-10-07 | Genesupport SA | Non-invasive method for detecting a fetal chromosomal aneuploidy |
| US20140242582A1 (en) | 2013-02-28 | 2014-08-28 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities using ligation-based detection and digital pcr |
| GB2528205B (en) | 2013-03-15 | 2020-06-03 | Guardant Health Inc | Systems and methods to detect rare mutations and copy number variation |
| US10017807B2 (en) | 2013-03-15 | 2018-07-10 | Verinata Health, Inc. | Generating cell-free DNA libraries directly from blood |
| JP7451070B2 (ja) | 2013-11-07 | 2024-03-18 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ヒトミクロビオームおよびその成分の分析のための無細胞核酸 |
| WO2015085105A1 (en) | 2013-12-04 | 2015-06-11 | University Of Alaska Fairbanks | Methods and compositions for enriching non-host sequences in host samples |
| US10450650B2 (en) | 2015-09-24 | 2019-10-22 | The United States of America as represented by the Admininstrator of the National Aeronautics and Space Administration | Method of manufacturing large area graphene and graphene-based photonics devices |
| JP7577928B2 (ja) | 2019-06-19 | 2024-11-06 | 株式会社リコー | トナー及び現像剤 |
-
2014
- 2014-11-07 JP JP2016528200A patent/JP7451070B2/ja active Active
- 2014-11-07 AU AU2014346562A patent/AU2014346562B2/en active Active
- 2014-11-07 KR KR1020247008723A patent/KR102930443B1/ko active Active
- 2014-11-07 CA CA2929557A patent/CA2929557C/en active Active
- 2014-11-07 EP EP14860535.5A patent/EP3066236B1/en active Active
- 2014-11-07 CN CN202110128389.8A patent/CN112877472A/zh active Pending
- 2014-11-07 IL IL285106A patent/IL285106B/en unknown
- 2014-11-07 EP EP22185212.2A patent/EP4130350A1/en active Pending
- 2014-11-07 WO PCT/US2014/064669 patent/WO2015070086A1/en not_active Ceased
- 2014-11-07 MX MX2016005798A patent/MX383494B/es unknown
- 2014-11-07 KR KR1020267005115A patent/KR20260035294A/ko active Pending
- 2014-11-07 KR KR1020217001442A patent/KR102649364B1/ko active Active
- 2014-11-07 CN CN201480068555.8A patent/CN105829589B/zh active Active
- 2014-11-07 US US14/536,300 patent/US10450620B2/en active Active
- 2014-11-07 BR BR112016010095A patent/BR112016010095A2/pt not_active Application Discontinuation
- 2014-11-07 CA CA3207499A patent/CA3207499A1/en active Pending
- 2014-11-07 GB GB1608448.5A patent/GB2535382A/en not_active Withdrawn
- 2014-11-07 KR KR1020167013334A patent/KR102205950B1/ko active Active
-
2016
- 2016-05-03 IL IL245446A patent/IL245446B/en active IP Right Grant
- 2016-05-04 MX MX2021006893A patent/MX2021006893A/es unknown
- 2016-05-04 MX MX2021006897A patent/MX2021006897A/es unknown
- 2016-05-04 MX MX2020004247A patent/MX2020004247A/es unknown
- 2016-05-04 MX MX2021006895A patent/MX2021006895A/es unknown
-
2019
- 2019-08-28 US US16/554,286 patent/US12195814B2/en active Active
-
2020
- 2020-02-17 IL IL272714A patent/IL272714B/en active IP Right Grant
- 2020-10-28 IL IL278349A patent/IL278349B/en unknown
- 2020-12-03 JP JP2020200921A patent/JP7813512B2/ja active Active
-
2021
- 2021-06-14 US US17/347,247 patent/US11427876B2/en active Active
- 2021-06-14 US US17/347,180 patent/US11401562B2/en active Active
- 2021-06-14 US US17/347,138 patent/US11365453B2/en active Active
-
2023
- 2023-03-08 JP JP2023035735A patent/JP7739349B2/ja active Active
- 2023-04-20 US US18/137,350 patent/US20230349011A1/en active Pending
-
2025
- 2025-04-02 JP JP2025061469A patent/JP2025106376A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX383494B (es) | Ácidos nucleicos libres de células para el análisis del microbioma humano y componentes del mismo. | |
| CY1121907T1 (el) | Συζευγματα antidll3-antiσωmatoς-pbd και χρησεις αυτων | |
| CL2019001874A1 (es) | Inhibidores de tgfß1 isoforma-específicos contexto-permisivos y uso de los mismos. | |
| EP3685774C0 (en) | MEDICAL DEVICE WITH A VISIBLE PERFORATION DEVICE | |
| IL260400B (en) | Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies | |
| CY1121723T1 (el) | Συνδυασμος anti-lag-3 αντισωματων και anti-pd-1 αντισωματων για θεραπεια ογκων | |
| BR112017004059A2 (pt) | dispositivo de hemoperfusão utilizável | |
| PL3303632T3 (pl) | Terapeutyczne i diagnostyczne sposoby stosowane w nowotworze | |
| BR112017025828A2 (pt) | dispositivo de nó hospedeiro e métodos de uso com o mesmo. | |
| EA201792642A1 (ru) | Способы диагностики для т-клеточной терапии | |
| BR112017023868A2 (pt) | anticorpos anti-itga3, anticorpos anti-itga3 ativáveis, e métodos de uso dos mesmos | |
| BR112016028066A2 (pt) | composição de vacina; idessuis; ridessuis; anticorpo; composição parenteral; uso de uma proteína idessuis ou ridessuis; e célula hospedeira | |
| MX389560B (es) | Enfoque de inmunoterapias de combinación para el tratamiento del cancer. | |
| BR112016004305A2 (pt) | métodos diagnósticos e composições para tratamento de glioblastoma | |
| BR112016017986A2 (pt) | anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo | |
| MX2017005707A (es) | Metodos para seleccionar una linea de celulas t y el donador de la misma para terapia celular adoptiva. | |
| PT3200582T (pt) | Composições, kits e métodos para induzir citorresistência adquirida com utilização de indutores de proteínas de stress | |
| CL2016002794A1 (es) | Vacuna de péptido que comprende un péptido ras mutante y un agente quimioterapéutico | |
| EP3789757C0 (en) | BLOOD ANALYZER AND ANALYSIS METHOD | |
| IL245936A0 (en) | Methods of treating hematological cancers and predicting clinical sensitivity to leanlidomide using biomarkers | |
| MX2022010954A (es) | Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. | |
| MA50358A (fr) | Sémaglutide en thérapie médicale | |
| CO2020008863A2 (es) | Biomarcadores de tolerancia inmunitaria inducida por metotrexato | |
| EP3713489C0 (en) | INTEGRATED BLOOD TESTING DEVICE | |
| BR112016028838A2 (pt) | anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer |